Advertisement

Topics

Drugmaker Endo cuts full-year sales forecast, shares slide

16:47 EDT 8 Aug 2017 | Topix

REUTERS: Endo International Plc on Tuesday lowered its full-year revenue forecast, saying it expected lower sales of branded drugs to add to the pricing pressure its generic drugs are facing, sending the company's shares to their lowest since 2003. Generic drugmakers are being hurt by an acceleration in the decline of drug prices as U.S. retail pharmacies wield more leverage during purchases at a time when regulators are pushing for faster approval of these copycat drugs.

Original Article: Drugmaker Endo cuts full-year sales forecast, shares slide

NEXT ARTICLE

More From BioPortfolio on "Drugmaker Endo cuts full-year sales forecast, shares slide"

Quick Search
Advertisement